Annual report pursuant to Section 13 and 15(d)

Note 21 - Financial Information About the Parent, the Issuer and the Guarantors (Tables)

v2.4.0.6
Note 21 - Financial Information About the Parent, the Issuer and the Guarantors (Tables)
12 Months Ended
Jun. 30, 2012
Condensed Consolidating Balance Sheet [Table Text Block]
   
Parent
   
Issuer
   
Guarantors
   
Non-Guarantors
   
Eliminations
   
Consolidated
 
Assets
                                   
Current assets:
                                   
Cash and cash equivalents
  $ -     $ 64,946     $ 12,276     $ 2,499     $ -     $ 79,721  
Marketable securities
    -       9,005       -       -       -       9,005  
Accounts receivable, net
    -       14,648       263       8       -       14,919  
Inventories
    -       -       182,382       4,736       (31,379 )     155,739  
Prepaid expenses and other current assets
    -       6,191       14,689       2,528       -       23,408  
Intercompany receivables
    -       829,913       273,536       (8,515 )     (1,094,934 )     -  
Total current assets
    -       924,703       483,146       1,256       (1,126,313 )     282,792  
Property, plant and equipment, net
    -       9,078       272,228       14,389       -       295,695  
Goodwill and other intangible assets
    -       37,905       7,223       -       -       45,128  
Restricted cash and investments
    -       15,416       -       -       -       15,416  
Other assets
    -       4,948       809       -       -       5,757  
Investment in affiliated companies
    652,868       (108,864 )     -       -       (544,004 )     -  
Total assets
  $ 652,868     $ 883,186     $ 763,406     $ 15,645     $ (1,670,317 )   $ 644,788  
Liabilities and Shareholders’ Equity
                                               
Current liabilities:
                                               
Current maturities of long-term debt
  $ -     $ -     $ 250     $ -     $ -     $ 250  
Customer deposits
    -       -       62,479       2,986       -       65,465  
Accounts payable
    -       7,126       19,695       494       -       27,315  
Accrued expenses and other current liabilities
    2,713       35,752       18,537       1,045       -       58,047  
Intercompany payables
    328,287       327       756,513       9,807       (1,094,934 )     -  
Total current liabilities
    331,000       43,205       857,474       14,332       (1,094,934 )     151,077  
Long-term debt
    -       152,986       1,264       -       -       154,250  
Other long-term liabilities
    -       3,641       13,874       78       -       17,593  
Total liabilities
    331,000       199,832       872,612       14,410       (1,094,934 )     322,920  
Shareholders’ equity
    321,868       683,354       (109,206 )     1,235       (575,383 )     321,868  
Total liabilities and shareholders’ equity
  $ 652,868     $ 883,186     $ 763,406     $ 15,645     $ (1,670,317 )   $ 644,788  
   
Parent
   
Issuer
   
Guarantors
   
Non-Guarantors
   
Eliminations
   
Consolidated
 
Assets
                                   
Current assets:
                                   
Cash and cash equivalents
  $ -     $ 69,763     $ 7,716     $ 1,040     $ -     $ 78,519  
Marketable securities
    -       12,909       -       -       -       12,909  
Accounts receivable, net
    -       13,609       174       1,253       -       15,036  
Inventories
    -       -       164,938       4,554       (27,800 )     141,692  
Prepaid expenses and other current assets
    -       4,598       14,866       908       -       20,372  
Intercompany receivables
    -       784,285       249,461       (8,423 )     (1,025,323 )     -  
Total current assets
    -       885,164       437,155       (668 )     (1,053,123 )     268,528  
Property, plant and equipment, net
    -       8,023       276,057       10,773       -       294,853  
Goodwill and other intangible assets
    -       37,905       7,223       -       -       45,128  
Restricted cash and investments
    -       16,391       -       -       -       16,391  
Other assets
    -       2,700       725       -       -       3,425  
Investment in affiliated companies
    602,699       (93,132 )     -       -       (509,567 )     -  
Total assets
  $ 602,699     $ 857,051     $ 721,160     $ 10,105     $ (1,562,690 )   $ 628,325  
Liabilities and Shareholders’ Equity
                                               
Current liabilities:
                                               
Current maturities of long-term debt
  $ -     $ -     $ 19     $ -     $ -     $ 19  
Customer deposits
    -       -       59,633       3,016       -       62,649  
Accounts payable
    -       7,333       19,233       392       -       26,958  
Accrued expenses and other current liabilities
    2,130       43,212       18,746       902       -       64,990  
Intercompany payables
    318,882       597       702,748       3,096       (1,025,323 )     -  
Total current liabilities
    321,012       51,142       800,379       7,406       (1,025,323 )     154,616  
Long-term debt
    -       164,832       181       -       -       165,013  
Other long-term liabilities
    -       4,392       14,474       109       -       18,975  
Deferred income taxes
    -       8,034       -       -       -       8,034  
Total liabilities
    321,012       228,400       815,034       7,515       (1,025,323 )     346,638  
Shareholders’ equity
    281,687       628,651       (93,874 )     2,590       (537,367 )     281,687  
Total liabilities and shareholders’ equity
  $ 602,699     $ 857,051     $ 721,160     $ 10,105     $ (1,562,690 )   $ 628,325  
Condensed Consolidating Statement of Operations [Table Text Block]
   
Parent
   
Issuer
   
Guarantors
   
Non-Guarantors
   
Eliminations
   
Consolidated
 
Net sales
  $ -     $ 456,895     $ 787,295     $ 33,417     $ (548,234 )   $ 729,373  
Cost of sales
    -       341,365       523,064       19,311       (544,655 )     339,085  
Gross profit
    -       115,530       264,231       14,106       (3,579 )     390,288  
Selling, general and administrative expenses
    180       45,690       280,565       14,241       -       340,676  
Restructuring and impairment charge, (credit) net
    -       -       (85 )     -       -       (85 )
Total operating expenses
    180       45,690       280,480       14,241       -       340,591  
Operating income (loss)
    (180 )     69,840       (16,249 )     (135 )     (3,579 )     49,697  
Interest and other miscellaneous income, net
    49,874       (15,403 )     216       17       (34,142 )     562  
Interest and other related financing costs
    -       8,997       23       -       -       9,020  
Income before income tax expense
    49,694       45,440       (16,056 )     (118 )     (37,721 )     41,239  
Income tax expense (benefit)
    -       (8,013 )     (523 )     81       -       (8,455 )
Net income/(loss)
  $ 49,694     $ 53,453     $ (15,533 )   $ (199 )   $ (37,721 )   $ 49,694  
   
Parent
   
Issuer
   
Guarantors
   
Non-Guarantors
   
Eliminations
   
Consolidated
 
Net sales
  $ -     $ 423,458     $ 718,660     $ 29,861     $ (493,019 )   $ 678,960  
Cost of sales
    -       321,706       481,814       16,198       (490,218 )     329,500  
Gross profit
    -       101,752       236,846       13,663       (2,801 )     349,460  
Selling, general and administrative expenses
    180       43,791       259,539       12,891       -       316,401  
Restructuring and impairment charge, (credit) net
    -       -       1,126       -       -       1,126  
Total operating expenses
    180       43,791       260,665       12,891       -       317,527  
Operating income (loss)
    (180 )     57,961       (23,819 )     772       (2,801 )     31,933  
Interest and other miscellaneous income, net
    29,430       (17,842 )     232       5       (6,261 )     5,564  
Interest and other related financing costs
    -       10,847       279       -       -       11,126  
Income before income tax expense
    29,250       29,272       (23,866 )     777       (9,062 )     26,371  
Income tax expense (benefit)
    -       (2,959 )     -       80       -       (2,879 )
Net income/(loss)
  $ 29,250     $ 32,231     $ (23,866 )   $ 697     $ (9,062 )   $ 29,250  
   
Parent
   
Issuer
   
Guarantors
   
Non-Guarantors
   
Eliminations
   
Consolidated
 
Net sales
  $ -     $ 363,038     $ 603,191     $ 22,463     $ (398,638 )   $ 590,054  
Cost of sales
    -       286,185       412,992       11,939       (401,339 )     309,777  
Gross profit
    -       76,853       190,199       10,524       2,701       280,277  
Selling, general and administrative expenses
    195       41,930       236,791       10,659       -       289,575  
Restructuring and impairment charge, net
    -       -       2,437       -       -       2,437  
Total operating expenses
    195       41,930       239,228       10,659       -       292,012  
Operating income (loss)
    (195 )     34,923       (49,029 )     (135 )     2,701       (11,735 )
Interest and other miscellaneous income, net
    (44,121 )     (44,539 )     106       16       93,410       4,872  
Interest and other related financing costs
    -       11,619       305       -       -       11,924  
Income before income tax expense
    (44,316 )     (21,235 )     (49,228 )     (119 )     96,111       (18,787 )
Income tax expense
    -       25,529       -       -       -       25,529  
Net income/(loss)
  $ (44,316 )   $ (46,764 )   $ (49,228 )   $ (119 )   $ 96,111     $ (44,316 )
   
Parent
   
Issuer
   
Guarantors
   
Non-Guarantors
   
Eliminations
   
Consolidated
 
Net cash provided by (used in) operating activities
  $ 9,187     $ 3,939     $ 18,441     $ 6,134     $ -     $ 37,701  
Cash flows from investing activities:
                                               
Capital expenditures
    -       (1,952 )     (15,721 )     (5,211 )     -       (22,884 )
Acquisitions
    -       -       (520 )     -       -       (520 )
Proceeds from the disposal of property, plant and equipment
    -       12       1,861       -       -       1,873  
Change in restricted cash and investments
    -       975       -       -       -       975  
Purchase of marketable securities
    -       (3,647 )     -       -       -       (3,647 )
Proceeds from the sale of marketable securities
    -       7,230       -       -       -       7,230  
Other
    -       305       511       -       -       816  
Net cash provided by (used in) investing activities
    -       2,923       (13,869 )     (5,211 )     -       (16,157 )
Cash flows from financing activities:
                                               
Payments on long-term debt
    -       (11,917 )     (287 )     -       -       (12,204 )
Purchases and other retirements of company stock
    (1,350 )     -       -       -       -       (1,350 )
Proceeds from issuance of common stock
    225       -       -       -       -       225  
Excess tax benefits from share-based payment
arrangements
    -       238       -       -       -       238  
Proceeds from noncontrolling interest
    -       -       275       -       -       275  
Dividends paid
    (8,062 )     -       -       -       -       (8,062 )
Net cash provided by (used in) financing activities
    (9,187 )     (11,679 )     (12 )     -       -       (20,878 )
Effect of exchange rate changes on cash
    -       -       -       536       -       536  
Net decrease in cash and cash equivalents
    -       (4,817 )     4,560       1,459       -       1,202  
Cash and cash equivalents – beginning of period
    -       69,763       7,716       1,040       -       78,519  
Cash and cash equivalents – end of period
  $ -     $ 64,946     $ 12,276     $ 2,499     $ -     $ 79,721  
   
Parent
   
Issuer
   
Guarantors
   
Non-Guarantors
   
Eliminations
   
Consolidated
 
Net cash provided by operating activities
  $ 11,055     $ 38,590     $ 10,672     $ 2,845     $ -     $ 63,162  
Cash flows from investing activities:
                                               
Capital expenditures
    -       (1,182 )     (5,017 )     (2,895 )     -       (9,094 )
Acquisitions
    -       -       (2,957 )     -       -       (2,957 )
Proceeds from the disposal of property, plant and equipment
    -       -       3,196       -       -       3,196  
Change in restricted cash and investments
    -       927       -       -       -       927  
Purchase of marketable securities
    -       (9,466 )     -       -       -       (9,466 )
Proceeds from the sale of marketable securities
    -       7,319       -       -       -       7,319  
Other
    -       432       -       -       -       432  
Net cash used in investing activities
    -       (1,970 )     (4,778 )     (2,895 )     -       (9,643 )
Cash flows from financing activities:
                                               
Payments on long-term debt
    -       (33,989 )     (3,898 )     -       -       (37,887 )
Purchases and other retirements of company stock
    (5,377 )     -       -       -       -       (5,377 )
Proceeds from issuance of common stock
    76       -       -       -       -       76  
Increase in deferred financing costs
    -       (137 )     -       -       -       (137 )
Dividends paid
    (5,754 )     -       -       -       -       (5,754 )
Net cash used in financing actvities
    (11,055 )     (34,126 )     (3,898 )     -       -       (49,079 )
Effect of exchange rate changes on cash
    -       -       -       227       -       227  
Net increase in cash and cash equivalents
    -       2,494       1,996       177       -       4,667  
Cash and cash equivalents – beginning of period
    -       67,269       5,720       863       -       73,852  
Cash and cash equivalents – end of period
  $ -     $ 69,763     $ 7,716     $ 1,040     $ -     $ 78,519  
   
Parent
   
Issuer
   
Guarantors
   
Non-Guarantors
   
Eliminations
   
Consolidated
 
Net cash provided by (used in) operating activities
  $ 5,800     $ 48,466     $ (4,272 )   $ 1,337     $ -     $ 51,331  
Cash flows from investing activities:
                                               
Capital expenditures
    -       (393 )     (6,706 )     (2,823 )     -       (9,922 )
Acquisitions
    -       -       (50 )     -       -       (50 )
Proceeds from the disposal of property, plant and equipment
    -       -       13,198       -       -       13,198  
Change in restricted cash and investments
    -       (17,318 )     -       -       -       (17,318 )
Purchase of marketable securities
    -       (11,364 )     -       -       -       (11,364 )
Proceeds from the sale of marketable securities
    -       200       -       -       -       200  
Other
    -       165       -       -       -       165  
Net cash used in investing activities
    -       (28,710 )     6,442       (2,823 )     -       (25,091 )
Cash flows from financing activities:
                                               
Payments on long-term debt
    -       -       (42 )     -       -       (42 )
Proceeds from issuance of common stock
    1       -       -       -       -       1  
Increase in deferred financing costs
    -       (199 )     -       -       -       (199 )
Dividends paid
    (5,801 )     -       -       -       -       (5,801 )
Net cash used in financing actvities
    (5,800 )     (199 )     (42 )     -       -       (6,041 )
Effect of exchange rate changes on cash
    -       -       -       693       -       693  
Net increase (decrease) in cash and cash equivalents
    -       19,557       2,128       (793 )     -       20,892  
Cash and cash equivalents – beginning of period
    -       47,712       3,592       1,656       -       52,960  
Cash and cash equivalents – end of period
  $ -     $ 67,269     $ 5,720     $ 863     $ -     $ 73,852